Related Experiment Video
Updated: Aug 24, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Update in atherothrombotic disease
Juan F Viles-Gonzalez1, Sunil X Anand, Carolina Valdiviezo
1Cardiovascular Biology Research Laboratory, Zena and Michael A. Wiener Cardiovascular Institute, Box 1030, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.
Insights
Advances in understanding atherothrombosis reveal complex pathogenesis beyond lipid accumulation. Key factors include endothelial dysfunction, inflammation, apoptosis, and tissue factor, influencing plaque thrombogenicity and acute coronary syndromes.
Area of Science:
- Cardiovascular Medicine
- Pathogenesis of Atherothrombosis
- Thrombotic Complications
Background:
- The understanding of atherothrombosis, encompassing atherosclerosis and its thrombotic complications, has significantly evolved over the last two decades.
- The traditional "lipid accumulation" hypothesis has been expanded to incorporate multiple factors in disease initiation and progression.
- Endothelial dysfunction is recognized as the earliest event in atherogenesis, with inflammation and apoptosis playing critical roles.
Purpose of the Study:
- To review emerging concepts in the pathogenesis of atherothrombotic disease.
- To discuss novel therapeutic approaches for managing atherothrombotic conditions.
- To integrate current understanding of molecular and cellular mechanisms driving atherothrombosis.
Main Methods:
- Review of recent scientific literature on atherothrombosis.
- Synthesis of data on endothelial dysfunction, inflammation, apoptosis, and tissue factor.
- Analysis of the role of "vulnerable blood" in acute coronary syndromes.
Main Results:
- Atherothrombosis pathogenesis is multifactorial, involving more than just lipid accumulation.
- Endothelial dysfunction, inflammation, apoptosis, and tissue factor are key contributors to plaque development and thrombogenicity.
- A hyperreactive blood state may account for a significant portion of acute coronary syndromes.
Conclusions:
- Current understanding of atherothrombosis integrates multiple pathogenic pathways.
- Targeting these pathways offers potential for new therapeutic strategies.
- Further research is needed to fully elucidate and exploit these emerging concepts for clinical benefit.
Abstract:
Crucial advances in our understanding of the pathogenesis of atherothrombosis, defined as atherosclerosis and its thrombotic complications, have been achieved during the past two decades. The historical hypothesis of pathogenesis ("lipid accumulation") has evolved to integrate several factors contributing to the initiation and evolution of this complex disease. Endothelial dysfunction is considered to be the earliest event in atherogenesis. Inflammation and apoptosis play critical roles in its progression and onset. Tissue factor is postulated to be a central actor in determining plaque thrombogenicity. A hyperreactive state of the blood ("vulnerable blood") may be responsible for one-third of all the acute coronary syndromes. This review will discuss emerging concepts in the pathogenesis of and therapeutic approaches to atherothrombotic disease.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease III: Medical Management